Target intelligence / Profile preview

Bcl2 proto-oncogene protein (Bcl-2)

Target: Bcl-2
Molecular classification: Apoptosis regulator, Proto-oncogene

Overview

Bcl-2 is a key regulator of apoptosis, primarily functioning to inhibit programmed cell death. It is located in the membranes of the endoplasmic reticulum, nuclear envelope, and outer mitochondrial membrane, preventing the release of cytochrome c and reactive oxygen species (ROS). Overexpression of Bcl-2 contributes to tumorigenesis by promoting cell survival and resistance to chemotherapy and radiation.

Other names: B cell lymphoma 2 protein

Mechanism of action

Bcl-2 inhibition

Biological functions

Apoptosis inhibitionCell survivalMitochondrial dynamicsMetabolic regulation

Disease associations

CancerLymphomaTreatment resistance

Safety considerations

Treatment resistancePotential for off-target effects

Biomarkers

Bcl-2 expression levels

Beyond the preview

Go deeper on Bcl2 proto-oncogene protein (Bcl-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bcl2 proto-oncogene protein (Bcl-2).

Explore the full profile